The translation of knowledge to practice lags in the health professions. We describe the eHealth promotion knowledge-to-action practice concept on how Diabetes Mellitus (DM) prevention can be readily incorporated into TeleHealth practice. In addition to means of targeting patients and encouraging them to participate in health behavior change, attention is given to the role of TeleHealth components of DM prevention and management. TeleHealth services with proven track records today can be broadly categorized into 3 groups: Teleconsultation, Telemonitoring, and Electronic Health Record. Teleconsultation allows patients to consult doctors about non-emergency medical conditions such as video call over an online link without having to step out of their house. Telemonitoring, on the other hand, helps healthcare professionals keep a close eye on patients dealing with chronic medical conditions such as vital signs of blood pressure and glucose levels fig1& fig2. In the back, electronic health record keeping ties the whole system together with no more paper work. It allows healthcare professionals to see a patient’s entire medical history, helping them make more accurate and timely diagnoses and treatment of their conditions.

Researched, close management of diabetic patients through monitoring showed significant reduction in glycemic level. Yet, the magnitude of its effects remains debatable, especially with the variation in patients’ characteristics (e.g. background, ability for self-management, medical condition, education). In Middle East, increasing awareness about telemonitroing and investigation of telemonitoring efficacy and cost-effectiveness is needed to prevent and manage DM by monitoring lifestyle parameters and control glycemic level as the main cause of DM complications.

Statement of the Problem: Despite the number of Americans prescribed diabetes medication and insulin, type 2 diabetes diagnoses increase annually at an alarming rate. Conventional treatment focuses on medication, dieting and managing this chronic disease. Medication has become the way to mask symptoms, not focus on the root cause for type 2 diabetes. Dieting focuses on caloric intake, carbohydrate counting, and food restriction. Teaching to manage diabetes negatively impacts the patient’s psychological ability to improve his or her health. Medication and insulin become a crutch. The outcome of this line of care appears to generate short-term results with lifetime need for medication and a progression to insulin. Findings: Shifting the focus to rest the pancreas through holistic lifestyle changes teaches long-term success for improvement. Striving for holistic view of the person focuses on many facets of a person’s life versus a narrow focus on the disease. This has far greater effect in putting the patient in control of one’s health. A patient that feels in control can improve their attitude, therefore, creating excitement when feeling and seeing the benefit of his or her lifestyle changes. Weight loss, the avoidance, reduction or elimination of medication or insulin, and improved A1c, is a result of holistic changes, rather than focusing on a number on a lab test. Data used is from my personal accomplishments and client cases. Conclusion & Significance: Physicians, due to time constraints, are unable to provide the highest level of insight and direction to a struggling patient. Struggling diabetes patients are seeking to reduce and eliminate medication and long-term success. Consistent support and education are key to identify areas that sabotage a patient’s efforts in making lifestyle changes to learn to rest the pancreas which in turn helps to reverse the effects of type 2 diabetes.

Glucose is an essential ingredient in our diet and we all need it to produce the energy for everyday living.  And while glucose is essential, too much glucose over too long of a time is toxic to our bodies.  Glucose toxicity leads to the development of Type 2 diabetes in both children and adults, demanding that our healthcare systems spend a huge amount on treating diabetes and its complications.Chronic hyperglycemia leads to insulin resistance.  Insulin is the hormone needed for glucose to enter our cells to produce energy.  Needing to make insulin in an attempt to lower blood sugar can in turn lead to an inability to make insulin.  When this happen as in the case of Type 2 diabetes, we may have to resort to injection of insulin in order to try to keep our blood glucose levels in the normal range.Glucose is not a passive bystander in our bloodstream but is a toxic and reactive compound.  Glucose reacts with all of the proteins in our body forming GLYCATED PROTEINS.  These glycated proteins progress to become what is known as ADVANCED GLYCATION ENDPRODUCTS or AGEs.  These AGEs are known to be the culprits in many disease complications including cardiovasular disease. Protein glycation is also be the cause of insulin resistance.  If insulin and the insulin receptors on cells become glycated, this changes their ability to effectively function. There is now an all-natural solution to the glucose toxicity problem.  In over 20 years of R&D and clinical studies, nutritional supplements have been proven to combat glucose toxicity.  Three important supplements having this ability are the amino acid LYSINE, the mineral ZINC and a vitamin, VITAMIN C.  Combining these three important supplements into one tablet makes a powerful weapon to combat glucose toxicity and protein glycation.  This weapon is Lysulin®.

Current therapy for type 2 diabetes and the history of studies proving the effectiveness of nutritional supplements will be presented along with recent data from double blind placebo controlled studies with Lysulin.

Diabetes mellitus (DM) is a powerful and independent risk factor for cardiovascular disease. The atherosclerosis process in diabetes is indistinguishable from that of the nondiabetic population, but it begins earlier and is often more extensive and more severe. AIF-1 promotes chemotaxis, spreading and migration of macrophages and vascular smooth muscle cells (VSMCs) which suggest a role of AIF-1 in the atherosclerotic plaque formation.Thus,This study determines the role of AIF-1 In the Egyptian Type 2 Diabetic Patients with Atherosclerosis. The level of AIF-1 was significantly higher in the diabetic atherosclerotic groups when compared to the control group (p=0.000). In diabetic atherosclerotic patients group, there was a significant positive correlation between CIMT and AIF-1 (r=0.468, p= 0.000) , denoting the possible role of elevated serum AIF-1 level  in atherosclerotic process.Thus, AIF-1 could be used as a marker of  atherosclerosis in diabetic patients.

The “Comprehensive ICF Core Set for Diabetes Mellitus“ is an application of the International Classification of Functioning, Disability and Health (ICF) and represents the typical spectrum of problems in functioning in patients with diabetes mellitus (DM). The International Classification of Functioning, Disability and Health (ICF) is a framework for describing and organizing information on functioning and disability. It provides a standard language and a conceptual basis for the definition and measurement of health and disability.

The aim of this study is to present a call to action framework using validated ICF Core Set for DM from the perspectives of physical therapists (PT) in Health Information System (HIS). Twenty-two PTs, from 11 countries, answered 1st round, 23 PTs completed the second and third Delphi rounds. PTs reached consensus on 49 ICF categories. 36/49 (73%) ICF categories are represented in the ICF Core Set for DM, while 13/49 (27%) categories are not represented in the ICF Core Set for DM. 5 concepts were linked to the ICF component of Personal Factors, which is not yet classified into detailed categories. The validity of the ICF Core Set for DM from the perspective of PTs was supported. The ICF appears to provide an effective framework for PTs in the field of DM. Therefore, it is worth using such framework in HIS and apply it in clinical practice (fig1 & 2).